ATE519849T1 - Herstellung von pravastatin - Google Patents

Herstellung von pravastatin

Info

Publication number
ATE519849T1
ATE519849T1 AT07786762T AT07786762T ATE519849T1 AT E519849 T1 ATE519849 T1 AT E519849T1 AT 07786762 T AT07786762 T AT 07786762T AT 07786762 T AT07786762 T AT 07786762T AT E519849 T1 ATE519849 T1 AT E519849T1
Authority
AT
Austria
Prior art keywords
pravastatin
gene
compactin
statin
conversion
Prior art date
Application number
AT07786762T
Other languages
English (en)
Inventor
Van Den Berg
Bernard Meijrink
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE519849T1 publication Critical patent/ATE519849T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT07786762T 2006-06-22 2007-06-19 Herstellung von pravastatin ATE519849T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06115917 2006-06-22
PCT/EP2007/056096 WO2007147827A2 (en) 2006-06-22 2007-06-19 Production of pravastatin

Publications (1)

Publication Number Publication Date
ATE519849T1 true ATE519849T1 (de) 2011-08-15

Family

ID=38650035

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07786762T ATE519849T1 (de) 2006-06-22 2007-06-19 Herstellung von pravastatin

Country Status (8)

Country Link
US (1) US20100048938A1 (de)
EP (1) EP2029750B1 (de)
JP (1) JP2009540811A (de)
CN (1) CN101490263B (de)
AT (1) ATE519849T1 (de)
DK (1) DK2029750T3 (de)
SI (1) SI2029750T1 (de)
WO (1) WO2007147827A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2274267T1 (sl) * 2008-04-02 2012-04-30 Dsm Sinochem Pharmaceuticals Nl B V Ekstrakcija pravastatina
CN102171328A (zh) * 2008-09-24 2011-08-31 帝斯曼知识产权资产管理有限公司 经改进的斯达汀生产
WO2010069914A1 (en) * 2008-12-19 2010-06-24 Dsm Ip Assets B.V. Statin transcription regulators
WO2012085191A1 (en) 2010-12-23 2012-06-28 Dsm Sinochem Pharmaceuticals Netherlands B.V. Crystalline form of pravastatine and process for the preparation thereof
WO2015161856A1 (en) 2014-04-23 2015-10-29 Danmarks Tekniske Universitet Statin resistance and export
JP6821598B2 (ja) 2015-12-07 2021-01-27 ザイマージェン インコーポレイテッド Ｃｏｒｙｎｅｂａｃｔｅｒｉｕｍ ｇｌｕｔａｍｉｃｕｍ由来のプロモーター
US9988624B2 (en) 2015-12-07 2018-06-05 Zymergen Inc. Microbial strain improvement by a HTP genomic engineering platform
US10544411B2 (en) 2016-06-30 2020-01-28 Zymergen Inc. Methods for generating a glucose permease library and uses thereof
EP3478833A4 (de) 2016-06-30 2019-10-02 Zymergen, Inc. Verfahren zum erzeugen einer bakteriellen hämoglobin-bibliothek und deren verwendung
JP7755921B2 (ja) 2019-03-29 2025-10-17 味の素株式会社 制御装置、制御方法およびプログラムならびに有機化合物の製造方法
CN115161355B (zh) * 2022-09-08 2022-11-25 上海现代制药股份有限公司 一种利用发酵工艺制备高稳定性普伐他汀的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728811D0 (en) * 1987-12-09 1988-01-27 Beecham Group Plc Novel substance
US5942423A (en) * 1995-06-07 1999-08-24 Massachusetts Institute Of Technology Conversion of compactin to pravastatin by actinomadura
AU9264598A (en) * 1997-08-22 1999-03-16 Gist-Brocades B.V. Statin production by fermentation
WO2000037608A2 (en) * 1998-12-07 2000-06-29 Sloan-Kettering Institute For Cancer Research Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
IL142619A (en) * 2000-04-18 2008-03-20 Daiichi Sankyo Co Ltd Gardens from a cluster of gardens
ATE258603T1 (de) * 2001-06-15 2004-02-15 Gnosis Srl Verfahren zur herstellung von pravastatin und lovastatin
JP2003116567A (ja) * 2001-10-15 2003-04-22 Sankyo Co Ltd 遺伝子クラスター
JP3961306B2 (ja) * 2002-02-06 2007-08-22 月桂冠株式会社 黒麹菌のフェリクローム生合成に関与するクラスター遺伝子
CN1244688C (zh) * 2003-07-09 2006-03-08 上海天伟生物制药有限公司 生产普伐他汀钠的微生物和方法

Also Published As

Publication number Publication date
EP2029750A2 (de) 2009-03-04
CN101490263B (zh) 2012-06-20
JP2009540811A (ja) 2009-11-26
DK2029750T3 (da) 2011-10-17
WO2007147827A3 (en) 2008-06-12
EP2029750B1 (de) 2011-08-10
US20100048938A1 (en) 2010-02-25
WO2007147827A2 (en) 2007-12-27
CN101490263A (zh) 2009-07-22
SI2029750T1 (sl) 2011-11-30

Similar Documents

Publication Publication Date Title
DK2029750T3 (da) Fremstilling af pravastatin
HUP0303526A2 (hu) Azetidinon-intermedier vegyületek enantioszelektiv szintézise
MY143771A (en) Low ph aerated products
ATE478043T1 (de) Verfahren zur herstellung von acylperoxiden
MY156222A (en) Enzyme associated with equol synthesis
NO20081636L (no) FAP - inhibitorer
NO20060544L (no) Enzymatiske prosesser for produksjon av 4-substituerte 3-hydroksysmorsyrederivater og naerliggende cyano, hydroksy substituerte karboksylsyre estere
DK1562444T3 (da) Fremgangsmåde til formindskelse af acrylamidindholdet i varmebehandlede levnedsmidler
WO2007134086A3 (en) Methods of treating fatty liver disease comprising inhibiting glucosphingolipid synthesis
EA200701822A1 (ru) Пиразолилкарбоксанилиды
DE502004011781D1 (de) Oxidoreduktase aus pichia capsulata
MX2009010224A (es) Microorganismos y metodos para la produccion de 1,2-propanodiol y acetol.
ATE463564T1 (de) Verwendung von phosphoketolase zur herstellung geeigneter metabolite
MY144672A (en) Inhibitors of cytosolic phospholipase a2
WO2007086618A8 (en) L-amino acid producing bacterium and method of producing l-amino acid
WO2006087120A8 (de) Pyrazolopyrimidine
WO2010101888A3 (en) Methods and compositions for treatment of tumor metastasis
WO2007014077A3 (en) Rnai modulation of the rho-a gene and uses thereof
CY1111768T1 (el) Νεος παραγοντας μειωσης τριγλυκεριδιου
DK1851322T3 (da) Fremgangsmåde til enantioselektiv enzymatisk reduktion af ketoforbindelser
EA201000180A1 (ru) Способ получения производных пиримидина
EA200600601A1 (ru) Производные аминопиридина в качестве ингибиторов индуцируемой no-синтазы
ITVA20030025A1 (it) Depolimerizzazione enzimatica di carbossimetilcellulosa e relativi prodotti.
DE502004011271D1 (de) Oxidoreduktase aus metschnikowia zobellii
DE602004029362D1 (de) Vermeidung von vorhofflimmern (af) mit der verwendung von statin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties